RESUMO
Aim: One third of HIV patients are co- infected with HCV. As HIV patients live longer this coinfection and its complications such as liver cirrhosis, hepatic carcinoma, metabolic syndrome are emerging as major manifestations of the disease that need to be dealt with promptly in order to avoid a reduction of the positive effects of highly active antiretroviral therapy (HAART) on HIV/AIDS introduced in 1996. Another system that could be affected by co-infection is the skeletal system. It has been shown that HIV itself and in combination with HCV could lead to a reduction in bone mineral density (BMD) predisposing to pathological fractures. It is thus important to determine the state of calcium metabolism among our HIV/HCV patients in order to forestall negative impacts on our patients who have been stable on HAART for several years. The majority of our patients are on combination therapy of Zidovudine, Lamivudine and Nevirapine. The hepatic complications of HIV/HCV co-infection have been well established. In our previous studies signs of hepatic inflammation have been demonstrated by raised aspartate transaminase (AST) and alanine transaminase (ALT) levels. However in this study we wish to also demonstrate liver damage through estimation of bilirubin levels. Methodology: Antibodies to HIV were determines using Unigold and determine. immunochromatographic device was used to detect anti-HCV. Total bilirubin and calcium were analyzed using vitros DT-60 card reader. Results: The majority of our patients were female. In group I up to %80. There was a statistically significant elevation of total bilirubin levels in HIV/HCV co-infected patients when compared to HIV mono-infected patients. There were statistically significant changes in calcium levels between the groups Conclusion: Information on HIV/HCV co-infection and its effects on calcium metabolism in this clinical instance appears to be scarce. Intensification of research is required to firmly establish the role of HIV/HCV co-infection on calcium metabolism in our clinical instance.
RESUMO
Introduction: It is becoming clear that a major complication of HIV patients on HAART is coinfection with hepatitis C and its attendant sequalae such as liver cirrhosis and carcinoma. The aim is to determine the prevalence of anaemia, transaminitis in these co-infected patients. Materials and Methods: Three groups of patients were studied. There were a total of 44 male and 106 females included in the study. No children were among. Those co-infected with both HIV and HCV (group I), HIV only (group II) and negative for both viruses (Group III). Each group consists of 50 patients each. HIV status was determined utilizing determine and Unigold to detect HIV antibodies. HCV was determined by detecting the anti-HCV antibody (IgG) using third generation ELISA kit from DIA.PRO, Italy. The haematological indices were determined using the Sysmex haematology analyser. Liver transaminases were determined from the sera of the participants using Randox kits and absolute CD4 positive lymphocyte cells were determined using Partec cyflow (SL Green). The results were statistically analysed. Results: No case of anaemia was detected. CD4 counts in group I patients (HIV /HCV positive) and group II patients were clearly reduced. The CD 4 counts were markedly reduced when compared to the controls (group III) P<0.005. The liver enzymes were markedly raised in coinfected patients. Conclusion: The major observations in our group of co-infected patients was marked transaminitis and reduced CD 4 counts in co-infected patients. It is necessary to determine HCV genotypes to explain why our patients have not presented with increased cirrhosis and hepatic carcinoma.
RESUMO
Background: In the north central Nigeria, observed haemoglobin concentration is often used to determine the packed cell volume of patients, especially by many laboratories that cannot afford the cost of micro-haematocrit centrifuge. Aim: The study was carried out to determine the accuracy of 3-fold haemoglobin conversion to haematocrit level in anaemic conditions. Materials and Methods: The study was conducted on 580 symptomatic (febrile) patients and 810 subclinically anaemic subjects attending some selected private medical laboratories, hospitals and clinics in Kuje Area Council of Federal Capital Territory (FCT), Abuja, Nigeria. Calculated haemotocrit was obtained by multiplying observed haemoglobin concentration by three while the observed haemoglobin was determined by colorimetric technique using Drabkin solution. Observed haematocrit was determined by using microhaematocrit technique. Mean observed and mean calculated haematocrit were statistically analyzed by students’ T-Test and findings compared. Results: Findings revealed a significant bias for higher degree of anaemia when 3-fold haemoglobin (calculated haematocrit) was employed than when observed haematocrit was used to determine anaemia in children within 1-10 years of age (T=2.1630, P<0.05). Also, this study showed a significant difference between mean calculated haematocrit and mean observed haematocrit in post-haemorrhagic conditions (T=3.0151, P<0.05). Conclusion: Use of direct haemoglobin estimation and derived haematocrit is advocated to diagnose anaemia in children and post-haemorrhagic conditions. Side laboratories are advised to enroll into proficiency testing programmes to monitor accuracy of their assay results.
RESUMO
Aims: A commercial rapid test kit for anti-Hepatitis C Virus (anti-HCV) detection was evaluated and compared for diagnosis of hepatitis C by detection of immunoglobulin G(IgG) antibodies against a third generation Enzyme Immunoassay(EIA) as gold standard. Methodology: A total of 560 patient serum samples were subjected to rapid screening with rapid test (immunochromatographic) strip supplied by Global Diagnostics and commercially prepared IgG capture EIA by DIA.PRO, Italy. Results: Of the 560 samples, anti HCV was detected in 31(5.54%) by ELISA, whereas only 17(3.04%) by strip method. This gives 100% specificity as no false positive was observed, but with 68.8% sensitivity. The number of false negative results was 14. The positive and negative predictive values were 100% and 97.42% respectively. Conclusion: The result pattern shows that sensitivity is compromised. It is therefore recommended that third generation ELISA is used for blood donors screening, to reduce transmission of hepatitis C virus through blood transfusion. When need arises to use strip for anti-HCV testing, such strip should be validated locally before its adoption because kits are directed against known range of strains of HCV and have minimum titer of antibody below which detection becomes impossible.
RESUMO
Stored blood is used for transfusion in humans but peroxidative processes occur in stored blood before transfusion. The aim of this study was to evaluate the influence of the length of storage on plasma antioxidant levels and RBCs antioxidant enzyme activity. Blood collected from 15 donors and preserved with anticoagulant (citerate phosphate; dextrose adenine (CPDA-1) were examined. The concentration of total antioxidant status (TAS); malondialdehyde (MDA) and potassium (K+) in the plasma as well as glutathione peroxidise (GSH - Px); glutathione superoxide dismutase (SOD) and catalase (CAT) activities in erythrocytes were determined on days 1;5;10;15;20;25;30;35 and 40 of storage. Day 1 of the study is the day of donation.A 24.8increase in plasma concentration of MDA and 15.8increase in the concentration K+ on day 15 were recorded (p0.05). A 27decrease in the plasma concentration of TAS was observed on day 20 compared with day 1 (p0.05). Similarly GSH-Px activity is stored RBC decreased by 17.1; on day 15 (p0.05). SOD activities reduced by 17.1on day 20; CAT activities reduced by 12.6on day 15 (in each case p0.05). In this study blood stored in CPDA-1 shows that those glutathione-dependent antioxidant enzymes systems in erythrocytes and antioxidant defence in plasma were depleting gradually depending on the day of storage. We concluded based on our finding that 10 days period can be considered a safe storage limits for transfusion in relation to oxidative stress the RBCs were subjected in the storage medium